Jpmorgan Chase & CO Shockwave Medical, Inc. Transaction History

Jpmorgan Chase & CO

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$191.17 - $325.63 $2.29 Million - $3.9 Million	-11,979 Reduced 1.09%	1,086,515 $354 Million
Q4 2023 Feb 12, 2024	BUY	$160.99 - $215.69 $34.2 Million - $45.9 Million	212,717 Added 24.01%	1,098,494 $209 Million
Q3 2023 Nov 14, 2023	BUY	$194.33 - $283.97 $9.84 Million - $14.4 Million	50,639 Added 6.06%	885,777 $176 Million
Q2 2023 Aug 11, 2023	SELL	$223.05 - $302.68 $97.8 Million - $133 Million	-438,609 Reduced 34.43%	835,138 $238 Million
Q1 2023 May 18, 2023	BUY	$175.41 - $217.92 $15.7 Million - $19.5 Million	89,419 Added 7.55%	1,273,747 $276 Million
Q1 2023 May 11, 2023	BUY	$175.41 - $217.92 $66.3 Million - $82.3 Million	377,818 Added 46.85%	1,184,328 $257 Million
Q4 2022 Feb 13, 2023	SELL	$204.38 - $296.82 $24.3 Million - $35.2 Million	-118,725 Reduced 12.83%	806,510 $166 Million
Q3 2022 Nov 14, 2022	SELL	$195.21 - $310.53 $37.9 Million - $60.4 Million	-194,376 Reduced 17.36%	925,235 $257 Million
Q2 2022 Aug 11, 2022	SELL	$115.91 - $214.48 $6.1 Million - $11.3 Million	-52,615 Reduced 4.49%	1,119,611 $214 Million
Q1 2022 May 11, 2022	SELL	$127.96 - $207.36 $4.79 Million - $7.76 Million	-37,432 Reduced 3.09%	1,172,226 $243 Million
Q4 2021 Feb 10, 2022	SELL	$165.13 - $241.83 $12.1 Million - $17.7 Million	-73,225 Reduced 5.71%	1,209,658 $216 Million
Q3 2021 Nov 12, 2021	BUY	$163.99 - $235.57 $210 Million - $302 Million	1,282,883 New	1,282,883 $264 Million

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.